Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 97, 10-21
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
- Structural Genomics Consortium (1097737)
- AbbVie
- Bayer Pharma AG
- Boehringer Ingelheim
- Canada Foundation for Innovation
- Eshelman Institute for Innovation
- Ontario Genomics Institute
- Innovative Medicines Initiative (115766)
This publication has 63 references indexed in Scilit:
- Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTsScientific Reports, 2013
- Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1Cell, 2011
- IFN-γ– and IL-10–expressing virus epitope-specific Foxp3+ T reg cells in the central nervous system during encephalomyelitisJournal of Experimental Medicine, 2011
- Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune diseaseNature Medicine, 2011
- Wnt/Ca2+/NFAT Signaling Maintains Survival of Ph+ Leukemia Cells upon Inhibition of Bcr-AblCancer Cell, 2010
- Decrease of Foxp3+ Treg Cell Number and Acquisition of Effector Cell Phenotype during Lethal InfectionImmunity, 2009
- The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammationNature Immunology, 2009
- Protein Arginine Methylation in Mammals: Who, What, and WhyMolecular Cell, 2009
- Protein lysine methyltransferase G9a acts on non-histone targetsNature Chemical Biology, 2008
- FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repressionProceedings of the National Academy of Sciences, 2007